• No results found

University of Groningen Disorders of bilirubin and lipid metabolism Blankestijn, Maaike

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Disorders of bilirubin and lipid metabolism Blankestijn, Maaike"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Disorders of bilirubin and lipid metabolism

Blankestijn, Maaike

DOI:

10.33612/diss.168960021

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2021

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Blankestijn, M. (2021). Disorders of bilirubin and lipid metabolism: models and targets of intervention. University of Groningen. https://doi.org/10.33612/diss.168960021

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

STELLINGEN Behorende bij het proefschrift

Disorders of bilirubin and lipid metabolism Models and targets of intervention

1. Activation of LXR and FXR is not a panacea for all metabolic conditions.

2. The use of heterozygous Gunn rats as normobilirubinemic controls is only justifiable under conditions leading to profound changes in severe unconjugated hyperbilirubinemia (this thesis). 3. TICE ≠ TIBE: Transintestinal cholesterol excretion is not

identical to transintestinal bilirubin excretion (this thesis).

4. The peroxisomal membrane protein 4 (PXMP4) does not exert an indispensable function in the peroxisome under physiological or PPARa-stimulated conditions (this thesis).

5. PXMP4 is not critically involved in transintestinal cholesterol excretion (this thesis).

6. A short-term dietary protein restriction at advanced age has the potential to improve aspects of metabolic health (this thesis). 7. The interaction between bilirubin and the nuclear receptor family

of PPARs could be key to the protective metabolic functions of bilirubin and may provide a promising clinical strategy in humans (Adapted from Hammoud et al. 2018, Creeden et al. 2021).

8. The most exciting phrase in science is not ‘Eureka!’ but ‘That’s funny…’ (Isaac Asimov).

9. Je moet gewoon niet te diep nadenken. Dan klopt alles (Herman Finkers).

Referenties

GERELATEERDE DOCUMENTEN

Chapter 3 The expression level of non-alcoholic fatty liver disease-related gene PNPLA3 in hepatocytes is highly influenced by hepatic lipid status.

Recently, we showed that niacin also reduces the hepatic expression and plasma levels of the pro- atherogenic cholesteryl ester transfer protein (CETP) in mouse

In contrast to NRs discussed above which were mainly characterized by significantly high expression in either parenchymal or non-parenchymal cells, five NRs were

Combined, these data show that fasting induces a similar response in PNPLA3 expression in fatty liver and white adipose tissue, suggesting that PNPLA3 may have

In the current study, a reduction in the hepatic MCP-1 expression was associated with decreased CD68 and ABCG1 gene expression in liver, and also a reduced number of macrophages

Concomitant with the plasma VLDL-lowering effect, treatment of both LUF compounds resulted in a more than 40% reduction in the expression levels of apolipoprotein

The LXR agonist T0901317 not only reduced plasma (V)LDL-cholesterol levels, but also significantly increased HDL-cholesterol level, leading to a 10-fold increased ratio

reduction with LXR activation. This can be explained by the difference in plaque composition and characteristics between initial and advanced lesion.. contain primarily